Adherance ≥ 4 hours/night to reduce PaCO<sub>2</sub> by 0.5 kPa at 3 months - Novel Ventilation Modes for NIV (AVAPS-AE): Are they valuable in COPD or other Respiratory Disorders - Novel Ventilatory Modes of NIV to Treat Chronic Respiratory Failure in COPD and Obesity